Skip to main content

Peer Review reports

From: Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines

Original Submission
18 Jul 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
5 Nov 2022 Reviewed Reviewer Report
14 Nov 2022 Reviewed Reviewer Report
29 Nov 2022 Reviewed Reviewer Report
28 May 2023 Author responded Author comments - Nyanbol Kuol
Resubmission - Version 3
28 May 2023 Submitted Manuscript version 3
13 Jun 2023 Author responded Author comments - Nyanbol Kuol
Resubmission - Version 4
13 Jun 2023 Submitted Manuscript version 4
19 Jun 2023 Author responded Author comments - Nyanbol Kuol
Resubmission - Version 5
19 Jun 2023 Submitted Manuscript version 5
27 Jun 2023 Author responded Author comments - Nyanbol Kuol
Resubmission - Version 6
27 Jun 2023 Submitted Manuscript version 6
9 Jul 2023 Reviewed Reviewer Report
29 Jul 2023 Reviewed Reviewer Report - Alyssa Schledwitz
29 Jul 2023 Reviewed Reviewer Report
5 Sep 2023 Author responded Author comments - Nyanbol Kuol
Resubmission - Version 7
5 Sep 2023 Submitted Manuscript version 7
6 Sep 2023 Author responded Author comments - Nyanbol Kuol
Resubmission - Version 8
6 Sep 2023 Submitted Manuscript version 8
14 Sep 2023 Reviewed Reviewer Report - Alyssa Schledwitz
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
16 Sep 2023 Editorially accepted
12 Oct 2023 Article published 10.1186/s12885-023-11410-3

You can find further information about peer review here.

Back to article page